Zoom Logo

New IDEAS: Consent Best Practices: Essential Elements and Cultural Considerations - Shared screen with speaker view
Anna Leonard
29:37
What about scrubs?
Anna Leonard
29:52
does that also create a situation of undue influence?
Yasmeen Shabbir
41:01
please share study slides and recording after the meeting. Thank you
Mariela Rodriguez
41:54
Slides, recording, and resources will be shared after the presentation
Lucy Hanna
51:18
Just a reminder to everyone that this is NOT a randomized study. Randomization should not be discussed.
Kirsten Shuler
52:34
I just want to say "thank you!" for the comment about using "participant" rather then "subject". I've had people comment that "subject" make them feel like a lab rat.
Yasmeen Shabbir
53:13
great. Thank you
Emily Glavin
54:45
Thanks Lucy! For additional questions or concerns about the protocol or operations, please email newideas@acr.org
mary stroud
55:34
Can you unmute me?
Kirsten Shuler
56:13
Good point! I would always say "if you become a participant" rather than saying for example, "subjects in the study will undergo.."
mary stroud
56:46
Never mind Stephanie covered it!
Kim Tarver
56:53
Excellent presentation. Thank you!
Lucy Hanna
58:22
I can help with that question a bit
Yasmeen Shabbir
58:43
I have a patient visit due now. Thank you and take care everyone.
mary stroud
59:57
Thanks Lucy, great examples
Anna Leonard
59:58
Also for FDA audits the PHI needs to be disclosed
mary stroud
01:00:46
Agree with regulatory audits, standard language
Janet Han
01:02:55
Thank you for such an impactful, well-organized presentation!
Stephanie Mayers
01:03:03
Thanks for the great presentation, Casey, Marissa and Jasmine!
Anna Leonard
01:03:09
Thank you!